Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Hellmich

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Biomolecules|August 27, 2021
Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition ConceptMark R Hellmich, Celia Chao, Katalin Módis, et al.
Pharmacological Research|August 14, 2016
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancerNadiya Druzhyna, Bartosz Szczesny, Gabor Olah, et al.
Redox Biology|August 7, 2022
Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesisKetan K Thanki, Paul Johnson, Edward J Higgins, et al.
Cancer Research|September 20, 2017
Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes CarcinogenesisChes'Nique M Phillips, John R Zatarain, Michael E Nicholls, et al.
Molecular Medicine (Cambridge, Mass.)|June 4, 2016
Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approachCelia Chao, John R Zatarain, Ye Ding, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Biomolecules|August 27, 2021
Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition ConceptMark R Hellmich, Celia Chao, Katalin Módis, et al.
Pharmacological Research|August 14, 2016
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancerNadiya Druzhyna, Bartosz Szczesny, Gabor Olah, et al.
Redox Biology|August 7, 2022
Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesisKetan K Thanki, Paul Johnson, Edward J Higgins, et al.
Cancer Research|September 20, 2017
Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes CarcinogenesisChes'Nique M Phillips, John R Zatarain, Michael E Nicholls, et al.
Molecular Medicine (Cambridge, Mass.)|June 4, 2016
Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approachCelia Chao, John R Zatarain, Ye Ding, et al.
Pageof 7